Senior insider sale
President & CEO at ULTRAGENYX PHARMACEUTICAL INC. — senior position signals high conviction
$908.9K
20K shares
What this filing means
KAKKIS EMIL D plans to sell 20K shares of ULTRAGENYX PHARMACEUTICAL INC. valued at approximately $908.9K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 12/30/2024ACC: 0001971857-24-000911
DirectorOfficer· President & CEO
Since Mar 2026
20K
Shares to sell
$908.9K
Approx. market value
11.73K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
FOUNDERS SHARES
CASH
4/27/2010
11.73KTotal acquired11.73K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
4/27/2010 | FOUNDERS SHARES CASH | 11.73K | — |
| Total | 11.73K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
8.27K
Market value
$413.6K
12/10/2024
Planned — Approximate Date
NASDAQPlanned
Units to sell
11.73K
Market value
$495.3K
12/30/2024
Total
Units
20K
Value
$908.9K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
12/10/2024 | 8.27K | $413.6K | — | Completed |
| Planned — Approximate Date | ||||
12/30/2024 | 11.73K | $495.3K | NASDAQ | Planned |
| Total | 20K | $908.9K | ||